The latest update of “Global Retinal Disease Therapeutics Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Retinal Disease Therapeutics Market.
Overview of the Retinal Disease Therapeutics Market:
There are multiple treatments available for retinal disease. In addition to vitamin supplements, laser surgery, and medications, eye doctors can perform retinal detachment surgery to restore vision. Injections of anti-VEGF drugs, such as bevacizumab (Avastin (r)), can be used to prevent abnormal blood vessels from growing in the retina and causing vision loss. These procedures are generally one-time treatments, but follow-up visits are important to monitor the effectiveness of treatment. There are several warning signs of retinal disease. These symptoms are related to a larger retinal problem and can indicate that a person may have a condition that affects the retina. Many types of eye problems have similar symptoms, including macular degeneration, which affects the center of the visual field.
Drivers:
Increasing cases of eye disorders in parallel to the growing caseload of diabetes are expected to augment the growth of the global retinal disease therapeutics market throughout the forecast period. For instance, in December 2021, the U.S. Centers for Disease Control and Prevention (CDC) reported that around 1.5 million people in the U.S. are suffering from diabetic macular edema (DME).
Furthermore, the implementation of favorable reimbursement policies by several governments is expected to support the growth of the global retinal disease therapeutics market over the forecast period.
Restraints:
Frequent cancelation or suspension of clinical appointments as a result of the COVID-19 pandemic, combined with the lack of clinical settings available in developing countries, is expected to limit the global retinal disease therapeutics market's growth.
Regional Insights:
Geographically, North America dominated the global retinal disease therapeutics market owing to the increasing cases of age-related macular degeneration (AMD) in the elderly population and increasing research activities to develop retinal disease treatments.
Another notable region is Asia Pacific, which is performing well in the global retinal disease therapeutics market on account of the favorable compensation regulations imposed by the local governments, rising cases of genetic blindness, and increasing adoption of research partnerships among major market players.
Competitive Landscape:
- Major companies contributing to the global retinal disease therapeutics market include Regeneron Pharmaceuticals, Inc., Novartis, Roche, Santen Pharmaceuticals, Allergan, and Merck.
- In February 2022, the Canadian Ophthalmological Society projected that one in four individuals in Canada would be diagnosed with macular degeneration by 2032.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Retinal Disease Therapeutics Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Retinal Disease Therapeutics Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Roche
- Novartis
- Regeneron Pharmaceuticals, Inc.
- Merck
- Allergan
- Santen Pharmaceutical
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Retinal Disease Therapeutics Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy
- Retinal Vein Occlusion
By Applications, the market is segmented into:
- Hospital Pharmacy
- Retail Pharmacy
- Others
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Disease Therapeutics Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Retinal Disease Therapeutics Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Retinal Disease Therapeutics Market
1.6.1 How the Covid-19 is Affecting the Retinal Disease Therapeutics Market
1.6.1.1 Retinal Disease Therapeutics Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Retinal Disease Therapeutics Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Retinal Disease Therapeutics Market Perspective (2015-2028)
2.2 Retinal Disease Therapeutics Market Growth Trends by Regions
2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Retinal Disease Therapeutics Market Historic Market Share by Regions (2015-2021)
2.2.3 Retinal Disease Therapeutics Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Retinal Disease Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Retinal Disease Therapeutics Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disease Therapeutics Market Players by Market Size
3.1.1 Global Top Retinal Disease Therapeutics Market Players by Revenue (2015-2021)
3.1.2 Global Retinal Disease Therapeutics Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Disease Therapeutics Market Concentration Ratio
3.2.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Market Revenue in 2019
3.3 Retinal Disease Therapeutics Market Key Players Head office and Area Served
3.4 Key Players Retinal Disease Therapeutics Market Product Solution and Service
3.5 Date of entering into Retinal Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Retinal Disease Therapeutics Market Historic Market Size by Type (2015-2021)
4.2 Global Retinal Disease Therapeutics Market Forecasted Market Size by Type (2021-2028)
5 Retinal Disease Therapeutics Market Breakdown Data by Application (2015-2028)
5.1 Global Retinal Disease Therapeutics Market Size by Application (2015-2021)
5.2 Global Retinal Disease Therapeutics Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Retinal Disease Therapeutics Market Size (2015-2021)
6.2 Retinal Disease Therapeutics Market Key Players in North America (2019-2021)
6.3 North America Retinal Disease Therapeutics Market Size by Type (2015-2021)
6.4 North America Retinal Disease Therapeutics Market Size by Application (2015-2021)
7 Europe
7.1 Europe Retinal Disease Therapeutics Market Size (2015-2021)
7.2 Retinal Disease Therapeutics Market Key Players in Europe (2019-2021)
7.3 Europe Retinal Disease Therapeutics Market Size by Type (2015-2021)
7.4 Europe Retinal Disease Therapeutics Market Size by Application (2015-2021)
8 China
8.1 China Retinal Disease Therapeutics Market Size (2015-2021)
8.2 Retinal Disease Therapeutics Market Key Players in China (2019-2021)
8.3 China Retinal Disease Therapeutics Market Size by Type (2015-2021)
8.4 China Retinal Disease Therapeutics Market Size by Application (2015-2021)
9 Japan
9.1 Japan Retinal Disease Therapeutics Market Size (2015-2021)
9.2 Retinal Disease Therapeutics Market Key Players in Japan (2019-2021)
9.3 Japan Retinal Disease Therapeutics Market Size by Type (2015-2021)
9.4 Japan Retinal Disease Therapeutics Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Retinal Disease Therapeutics Market Size (2015-2021)
10.2 Retinal Disease Therapeutics Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Retinal Disease Therapeutics Market Size by Type (2015-2021)
10.4 Southeast Asia Retinal Disease Therapeutics Market Size by Application (2015-2021)
11 India
11.1 India Retinal Disease Therapeutics Market Size (2015-2021)
11.2 Retinal Disease Therapeutics Market Key Players in India (2019-2021)
11.3 India Retinal Disease Therapeutics Market Size by Type (2015-2021)
11.4 India Retinal Disease Therapeutics Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Retinal Disease Therapeutics Market Size (2015-2021)
12.2 Retinal Disease Therapeutics Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Retinal Disease Therapeutics Market Size by Type (2015-2021)
12.4 Central & South America Retinal Disease Therapeutics Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Retinal Disease Therapeutics Market Introduction
13.4 Retinal Disease Therapeutics Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Retinal Disease Therapeutics Market Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Disease Therapeutics Market Revenue
Table 3. Ranking of Global Top Retinal Disease Therapeutics Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Retinal Disease Therapeutics Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Retinal Disease Therapeutics Market Players to Combat Covid-19 Impact
Table 10. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Retinal Disease Therapeutics Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Retinal Disease Therapeutics Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Retinal Disease Therapeutics Market Share by Regions (2015-2021)
Table 14. Global Retinal Disease Therapeutics Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Retinal Disease Therapeutics Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Retinal Disease Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Retinal Disease Therapeutics Market Players
Table 21. Global Retinal Disease Therapeutics Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Retinal Disease Therapeutics Market Share by Players (2015-2021)
Table 23. Global Top Retinal Disease Therapeutics Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics Market as of 2019)
Table 24. Global Retinal Disease Therapeutics Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Retinal Disease Therapeutics Market Product Solution and Service
Table 27. Date of entering into Retinal Disease Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 30. Global Retinal Disease Therapeutics Market Size Share by Type (2015-2021)
Table 31. Global Retinal Disease Therapeutics Market Revenue Market Share by Type (2021-2028)
Table 31. Global Retinal Disease Therapeutics Market Size Share by Application (2015-2021)
Table 33. Global Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 34. Global Retinal Disease Therapeutics Market Size Share by Application (2021-2028)
Table 35. North America Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 37. North America Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 38. North America Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 39. North America Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 40. North America Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 41. Europe Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 43. Europe Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 45. Europe Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 47. China Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 49. China Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 50. China Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 51. China Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 52. China Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 53. Japan Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 55. Japan Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 57. Japan Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 61. Southeast Asia Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 63. Southeast Asia Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 65. India Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 67. India Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 68. India Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 69. India Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 70. India Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Retinal Disease Therapeutics Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Retinal Disease Therapeutics Market Share (2019-2021)
Table 73. Central & South America Retinal Disease Therapeutics Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Retinal Disease Therapeutics Market Share by Type (2015-2021)
Table 75. Central & South America Retinal Disease Therapeutics Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Retinal Disease Therapeutics Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Retinal Disease Therapeutics Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Global Retinal Disease Therapeutics Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Retinal Disease Therapeutics Market Report Years Considered
Figure 8. Global Retinal Disease Therapeutics Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Retinal Disease Therapeutics Market Share by Regions: 2021 VS 2028
Figure 10. Global Retinal Disease Therapeutics Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Retinal Disease Therapeutics Market Share by Players in 2019
Figure 13. Global Top Retinal Disease Therapeutics Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Retinal Disease Therapeutics Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Market Revenue in 2019
Figure 15. North America Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Retinal Disease Therapeutics Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
Request Discount 
Inquire Before Buy
